Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
deregulations involved in the development and progression of human lymphomas. The successful candidate will contribute to a research program aimed at generating, interpreting, and developing in vivo CRISPR Cas9
-
We are looking for a highly motivated postdoctoral researcher to join our lab of neuroepigenetics at EPFL (http://graefflab.epfl.ch/) ! The focus of the lab are the epigenetic underpinnings
-
innovative therapies. The Functional Genomics Expertise Center provides advanced genome editing, CRISPR screening, and functional genomics support to research groups across CCB. We are seeking a molecular
-
innovative therapies. The Functional Genomics Expertise Center provides advanced genome editing, CRISPR screening, and functional genomics support to research groups across CCB. We are seeking a molecular
-
disease, particularly in the context of therapy resistance in colorectal cancer. We are looking for an ambitious cancer biologist to work in Dr Li laboratory who can integrate functional CRISPR screens with
-
peuplier, une espèce modèle à croissance rapide et d'une grande importance économique. La thèse utilisera la technologie CRISPR-Cas pour éditer le génome des peupliers et combiner rapidement des allèles
-
interests, you will have the opportunity to work with: High‑throughput functional genomics: pooled CRISPR and base‑editing screens, barcoded overexpression libraries, massively parallel reporter assays
-
HBIGS Heidelberg Biosciences International Graduate School | Heidelberg, Baden W rttemberg | Germany | 12 days ago
, stem cell homeostasis, proliferation and differentiation and is frequently dysregulated in human cancer. In this project you will develop and apply advanced CRISPR genome engineering methods
-
of São Paulo (UNIFESP), in Brazil, aims to investigate how CRISPR-Cas9-mediated genetic modification of Invariant Natural Killer T (iNKT) cells can modulate their antitumor activity and therapeutic
-
homeostasis. The Wang group has been using Cre-loxP/Flp-frt and CRISPR strategy to manipulate genes of interest and use chemogenetics/optogenetics strategy to manipulate neuronal activities in specific neuron